vs

Side-by-side financial comparison of 3D SYSTEMS CORP (DDD) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Oncology Institute, Inc. is the larger business by last-quarter revenue ($142.0M vs $106.3M, roughly 1.3× 3D SYSTEMS CORP). Oncology Institute, Inc. runs the higher net margin — -5.3% vs -18.4%, a 13.1% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs -4.3%). Oncology Institute, Inc. produced more free cash flow last quarter ($2.2M vs $-16.6M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 1.6%).

3D Systems Corporation is an American company based in Rock Hill, South Carolina, that engineers, manufactures, and sells 3D printers, 3D printing materials, 3D printed parts, and application engineering services. The company creates product concept models, precision and functional prototypes, master patterns for tooling, as well as production parts for direct digital manufacturing. It uses proprietary processes to fabricate physical objects using input from computer-aided design and manufact...

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

DDD vs TOI — Head-to-Head

Bigger by revenue
TOI
TOI
1.3× larger
TOI
$142.0M
$106.3M
DDD
Growing faster (revenue YoY)
TOI
TOI
+45.9% gap
TOI
41.6%
-4.3%
DDD
Higher net margin
TOI
TOI
13.1% more per $
TOI
-5.3%
-18.4%
DDD
More free cash flow
TOI
TOI
$18.8M more FCF
TOI
$2.2M
$-16.6M
DDD
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
1.6%
DDD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DDD
DDD
TOI
TOI
Revenue
$106.3M
$142.0M
Net Profit
$-19.5M
$-7.5M
Gross Margin
30.8%
Operating Margin
-21.3%
-4.9%
Net Margin
-18.4%
-5.3%
Revenue YoY
-4.3%
41.6%
Net Profit YoY
41.7%
43.0%
EPS (diluted)
$0.04
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DDD
DDD
TOI
TOI
Q4 25
$106.3M
$142.0M
Q3 25
$91.2M
$136.6M
Q2 25
$94.8M
$119.8M
Q1 25
$94.5M
$104.4M
Q4 24
$111.0M
$100.3M
Q3 24
$112.9M
$99.9M
Q2 24
$113.3M
$98.6M
Q1 24
$102.9M
$94.7M
Net Profit
DDD
DDD
TOI
TOI
Q4 25
$-19.5M
$-7.5M
Q3 25
$-18.1M
$-16.5M
Q2 25
$104.4M
$-17.0M
Q1 25
$-37.0M
$-19.6M
Q4 24
$-33.5M
$-13.2M
Q3 24
$-178.6M
$-16.1M
Q2 24
$-27.3M
$-15.5M
Q1 24
$-16.0M
$-19.9M
Gross Margin
DDD
DDD
TOI
TOI
Q4 25
30.8%
Q3 25
32.3%
Q2 25
38.1%
Q1 25
34.6%
Q4 24
31.0%
Q3 24
36.9%
Q2 24
41.6%
Q1 24
39.8%
Operating Margin
DDD
DDD
TOI
TOI
Q4 25
-21.3%
-4.9%
Q3 25
-23.4%
-5.9%
Q2 25
-16.2%
-9.4%
Q1 25
-38.9%
-9.5%
Q4 24
-27.4%
-11.9%
Q3 24
-160.0%
-13.9%
Q2 24
-23.3%
-16.6%
Q1 24
-38.7%
-19.0%
Net Margin
DDD
DDD
TOI
TOI
Q4 25
-18.4%
-5.3%
Q3 25
-19.8%
-12.1%
Q2 25
110.1%
-14.2%
Q1 25
-39.1%
-18.8%
Q4 24
-30.1%
-13.1%
Q3 24
-158.2%
-16.1%
Q2 24
-24.1%
-15.7%
Q1 24
-15.5%
-21.0%
EPS (diluted)
DDD
DDD
TOI
TOI
Q4 25
$0.04
$-0.04
Q3 25
$-0.14
$-0.14
Q2 25
$0.57
$-0.15
Q1 25
$-0.28
$-0.21
Q4 24
$-0.26
$-0.14
Q3 24
$-1.35
$-0.18
Q2 24
$-0.21
$-0.17
Q1 24
$-0.12
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DDD
DDD
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$95.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$240.4M
$-15.7M
Total Assets
$521.7M
$164.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DDD
DDD
TOI
TOI
Q4 25
$95.6M
Q3 25
$95.5M
Q2 25
$116.4M
Q1 25
$135.0M
Q4 24
$171.3M
Q3 24
$190.0M
Q2 24
$192.7M
$9.9M
Q1 24
$212.0M
$29.8M
Stockholders' Equity
DDD
DDD
TOI
TOI
Q4 25
$240.4M
$-15.7M
Q3 25
$221.1M
$-12.3M
Q2 25
$241.2M
$-9.0M
Q1 25
$145.6M
$5.1M
Q4 24
$176.2M
$3.6M
Q3 24
$218.0M
$15.5M
Q2 24
$381.7M
$29.2M
Q1 24
$408.4M
$41.3M
Total Assets
DDD
DDD
TOI
TOI
Q4 25
$521.7M
$164.7M
Q3 25
$554.5M
$163.6M
Q2 25
$587.8M
$159.8M
Q1 25
$583.4M
$164.0M
Q4 24
$608.8M
$172.7M
Q3 24
$658.3M
$179.2M
Q2 24
$821.5M
$179.6M
Q1 24
$857.2M
$204.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DDD
DDD
TOI
TOI
Operating Cash FlowLast quarter
$-14.7M
$3.2M
Free Cash FlowOCF − Capex
$-16.6M
$2.2M
FCF MarginFCF / Revenue
-15.7%
1.5%
Capex IntensityCapex / Revenue
1.8%
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-97.8M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DDD
DDD
TOI
TOI
Q4 25
$-14.7M
$3.2M
Q3 25
$-13.5M
$-12.6M
Q2 25
$-25.8M
$-10.2M
Q1 25
$-33.8M
$-5.0M
Q4 24
$-7.8M
$4.2M
Q3 24
$-801.0K
$819.0K
Q2 24
$-10.8M
$-15.7M
Q1 24
$-25.5M
$-15.9M
Free Cash Flow
DDD
DDD
TOI
TOI
Q4 25
$-16.6M
$2.2M
Q3 25
$-15.8M
$-13.2M
Q2 25
$-28.8M
$-11.4M
Q1 25
$-36.6M
$-5.3M
Q4 24
$-13.1M
$2.4M
Q3 24
$-4.4M
$417.0K
Q2 24
$-14.7M
$-17.5M
Q1 24
$-28.7M
$-16.5M
FCF Margin
DDD
DDD
TOI
TOI
Q4 25
-15.7%
1.5%
Q3 25
-17.3%
-9.7%
Q2 25
-30.4%
-9.5%
Q1 25
-38.7%
-5.1%
Q4 24
-11.8%
2.4%
Q3 24
-3.9%
0.4%
Q2 24
-13.0%
-17.7%
Q1 24
-27.9%
-17.4%
Capex Intensity
DDD
DDD
TOI
TOI
Q4 25
1.8%
0.7%
Q3 25
2.5%
0.4%
Q2 25
3.1%
1.0%
Q1 25
3.0%
0.3%
Q4 24
4.8%
1.8%
Q3 24
3.2%
0.4%
Q2 24
3.5%
1.9%
Q1 24
3.1%
0.6%
Cash Conversion
DDD
DDD
TOI
TOI
Q4 25
Q3 25
Q2 25
-0.25×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DDD
DDD

Products$62.6M59%
Services$43.7M41%

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons